** U.S.-listed shares of drugmaker Bausch Health Companies
BHC.TO fall ~21.6% to $5.94
** According to analysts, data analytics agency Reorg
reported that BHC was negotiating a potential prepackaged
Chapter 11 bankruptcy filing
** Bausch in a statement says it has not been involved in
discussions with its creditors regarding bankruptcy proceedings
** Reuters could not independently verify the report
** Including session's move, BHC stock down 26% YTD
(Reporting by Christy Santhosh)
((Christy.Santhosh@thomsonreuters.com))